Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone

Author： Bailey Clifford J Green Brian D Flatt Peter R

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.8, 2010-08, pp. : 1017-1025

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus

By Chwieduk Claudine M.

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 349-361

Adis International

Access to resources Recommend Favorite

Sitagliptin/metformin fixed-dose combination: a guide to its use in type 2 diabetes mellitus

Drugs & Therapy Perspectives, Vol. 27, Iss. 9, 2011-09 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus

By Ono Yuri Kameda Hiraku Cho Kyu Yong

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 361-370

Informa Healthcare

Access to resources Recommend Favorite

Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus

By Inoue Masahiro

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2257-2268

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone combination therapy good value in type 2 diabetes

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite